Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boraschi

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Immunology|November 1, 1981
Natural killer activity of gut mucosal lymphoid cells in miceA Tagliabue, W Luini, D Soldateschi, et al.
Lymphokine Research|January 1, 1987
Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routesL Nencioni, L Villa, A Tagliabue, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1983
Peyer's patch lymphocytes express natural cytotoxicity but not natural killer activityA Tagliabue, L Villa, G Scapigliati, et al.
Lymphokine Research|January 1, 1989
Interleukin 1 stimulates production of LTC4 and other eicosanoids by macrophagesS Censini, M Bartalini, A Tagliabue, et al.
Clinical and Experimental Immunology|June 1, 1984
Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in miceA Tagliabue, L Nencioni, L Villa, et al.
Infection and Immunity|February 1, 1985
Modulation of in vitro natural cell-mediated activity against enteropathogenic bacteria by simple sugarsL Nencioni, L Villa, D Boraschi, et al.
International Journal of Immunopharmacology|January 1, 1981
Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responsesS Alberti, D Boraschi, W Luini, et al.
Immunology|April 1, 1977
Effect of carrier priming on antibody avidity in the in vivo and in vitro immune responseG Doria, G Agarossi, D Boraschi, et al.
European Journal of Immunology|July 1, 1980
Species-restricted effects of human and mouse lymphokines on macrophagesA Tagliabue, A Mantovani, D Boraschi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
The membrane form of the type II IL-1 receptor accounts for inhibitory functionD Neumann, C Kollewe, M U Martin, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Immunology|November 1, 1981
Natural killer activity of gut mucosal lymphoid cells in miceA Tagliabue, W Luini, D Soldateschi, et al.
Lymphokine Research|January 1, 1987
Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routesL Nencioni, L Villa, A Tagliabue, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1983
Peyer's patch lymphocytes express natural cytotoxicity but not natural killer activityA Tagliabue, L Villa, G Scapigliati, et al.
Lymphokine Research|January 1, 1989
Interleukin 1 stimulates production of LTC4 and other eicosanoids by macrophagesS Censini, M Bartalini, A Tagliabue, et al.
Clinical and Experimental Immunology|June 1, 1984
Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in miceA Tagliabue, L Nencioni, L Villa, et al.
Infection and Immunity|February 1, 1985
Modulation of in vitro natural cell-mediated activity against enteropathogenic bacteria by simple sugarsL Nencioni, L Villa, D Boraschi, et al.
International Journal of Immunopharmacology|January 1, 1981
Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responsesS Alberti, D Boraschi, W Luini, et al.
Immunology|April 1, 1977
Effect of carrier priming on antibody avidity in the in vivo and in vitro immune responseG Doria, G Agarossi, D Boraschi, et al.
European Journal of Immunology|July 1, 1980
Species-restricted effects of human and mouse lymphokines on macrophagesA Tagliabue, A Mantovani, D Boraschi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
The membrane form of the type II IL-1 receptor accounts for inhibitory functionD Neumann, C Kollewe, M U Martin, et al.
Pageof 13